|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
12/28/2012 7:14:38 AM
The pharmaceutical giant Novartis has published its plans to start redevelopment of its Horsham site. In August the County Times exclusively revealed that the company had decided to sell a significant part of its town campus in Wimblehurst Road, but confirmed its plans to lead world class respiratory research and associated development teams in Horsham. Last week a planning application was submitted to Horsham District Council (HDC) requesting permission to demolish several buildings on the site south of Parsonage Road covering nearly fives acres. These include production and store buildings of about three acres, the boiler house, chiller building, cycle rack, restaurant, document management centre, engineering building, ancillary services building, dispatch building and temporary offices. The iconic 1930s art deco building will be retained and enhanced. About 18 months ago the company announced a big reduction in its workforce there from nearly 1,000 to 440. At the time there were fears that this might be the ‘beginning of the end’ for the company’s involvement in the town. However the summer’s announcement stated the Novartis Institutes for BioMedical Research respiratory disease centre will continue to work on site and the UK Board had agreed the manufacturing would be moving away from Horsham as part of that process with last production scheduled for September 2013.
|
|
|
|
|
|
|
|
|
|
|